Correlation Between Pfizer and Charles River

Can any of the company-specific risk be diversified away by investing in both Pfizer and Charles River at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Charles River into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and Charles River Laboratories, you can compare the effects of market volatilities on Pfizer and Charles River and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Charles River. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Charles River.

Diversification Opportunities for Pfizer and Charles River

-0.06

Correlation Coefficient

Pfizer  Charles River

Good diversification

The 3 months correlation between Pfizer and Charles is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Charles River Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Charles River Labora and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Charles River. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Charles River Labora has no effect on the direction of Pfizer i.e., Pfizer and Charles River go up and down completely randomly.

Pair Corralation between Pfizer and Charles River

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Charles River. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 1.63 times less risky than Charles River. The stock trades about -0.09 of its potential returns per unit of risk. The Charles River Laboratories is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  21,750  in Charles River Laboratories on January 19, 2024 and sell it today you would earn a total of  1,405  from holding Charles River Laboratories or generate 6.46% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Pfizer Inc  vs.  Charles River Laboratories

Pfizer Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Charles River Labora

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Charles River Laboratories are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite quite fragile basic indicators, Charles River may actually be approaching a critical reversion point that can send shares even higher in May 2024.

Pair Trading with Pfizer and Charles River

The main advantage of trading using opposite Pfizer and Charles River positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Charles River can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Charles River will offset losses from the drop in Charles River's long position.

The idea behind Pfizer Inc and Charles River Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.